Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.RainDance Technologies, a provider of microdroplet-based solutions for human health and disease research, has commercially released its Sequence Enrichment Solution for sale in North America.
Subscribe to our email newsletter
The company has said that it has begun accepting orders for the solution and has started commercial production of the solution’s components for shipment during the first quarter of 2009. The company has also announced that comprehensive training and support services are available to maximize the operating performance of the solution.
The RainDance Sequence Enrichment Solution incorporates RainStorm technology for targeted sequencing applications of the human genome. It will enable the high-resolution analysis of genetic variation between individuals within populations at a level unmatched by current methodologies. The solution reportedly improves sample uniformity and reduces the selection bias typically associated with targeted sequencing, the company said.
Chris McNary, president and CEO of RainDance Technologies, said: “This milestone represents the first commercialized application of our exciting RainStorm microdroplet-based technology platform. It underscores the power of droplet-based biology to increase the depth of understanding about biological problems and increase the pace of biomedical discovery.”